DNA analysis revealed two gain-of-function mutations of the c-kit gene in the relapsing tumours: an in-frame mutation in exon 11, which encodes a region in the juxtamembrane domain; and a missense point mutation in exon 17, which encodes the tyrosine kinase (TK2) domain. The gene discussed is KIT; the disease is neoplasm.